I think everything hinges on the HIV BLA. If we can get that cleaned up, submitted, and approved then we are in a very good spot for any negotiations. I'm not sure what our revenue projections are once we're approved based on the Phase 3 HIV trial but we may even be able to do trials without partnering if we make enough. I was happy to hear that the clinical hold and BLA are priorities.